PRN: Obesity Drugs Price Analysis and Strategies 2016 - Research and Markets

21/feb/2017 13:10:16 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Obesity Drugs Price Analysis and Strategies 2016 - Research and Markets

 
[21-February-2017]
 

DUBLIN, Feb 21, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Obesity Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Obesity Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Obesity market.

The research answers the following questions:

  • What are the key drugs marketed for Obesity and their clinical attributes?
  • How are they positioned in the Global Obesity market?
  • What are the unit prices and annual treatment cost for Obesity therapies in different countries?
  • What are the drug pricing trends and how are they expected to change in the future?
  • How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Obesity drugs market?
  • What would be the ideal pricing strategy for a new pipeline therapy for Obesity?

Research Scope:

  • Obesity Treatment Options - Identify key drugs marketed and prescribed for Obesity in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
  • Obesity Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Obesity
  • Market Positioning - Identify how drugs are clinically and commercially positioned in the global Obesity market
  • Obesity Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Obesity in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
  • Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
  • Obesity New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

Key Topics Covered:

1. Obesity Treatment Options

2. Obesity Drugs Clinical Attributes

3. Obesity Drugs Market Positioning

4. Obesity Drugs Price Analysis

5. Obesity Drugs Price Benchmarks

6. Drug Pricing & Reimbursement Landscape

7. Obesity Drugs Price Forecast

8. Obesity Market Unmet Needs

9. Obesity New Drug Pricing

For more information about this report visit http://www.researchandmarkets.com/research/6jvksx/obesity_drugs

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl